QuidelOrtho (QDEL)

• Market cap: $1.95B
• 1 day: -2.71%
• 5 days: 3.98%
• 1 month: 11.27%
• 3 months: 2.5%
• 6 months: -20.64%
• Year to date: -36.21%
• 1 year: -38.02%
• 5 years: -83.17%
• 10 years: 39.53%
• Sector: Healthcare
• Industry: Medical Devices

About: QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.

Employees: 6,600

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

54% more call options, than puts

Call options by funds: $16.9M | Put options by funds: $11M

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

6.46% more ownership

Funds ownership: 111.05% [Q1] → 117.51% (+6.46%) [Q2]

4% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 47

1% less funds holding

Funds holding: 265 [Q1] → 262 (-3) [Q2]

13% less capital invested

Capital invested by funds: $2.62B [Q1] → $2.29B (-$328M) [Q2]

50% less funds holding in top 10

Funds holding in top 10: 6 [Q1] → 3 (-3) [Q2]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $26
• Avg. target: $33
• High target: $40

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

UBS Lu Li	$26	Neutral Maintained	7 Aug 2025
Citigroup Patrick Donnelly	$40	Buy Maintained	6 Aug 2025